Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. (Q33391788)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. |
scientific article |
Statements
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study (English)
Heinz Ludwig
Zdenek Adam
Elena Tóthová
Felix Keil
Eva Maria Autzinger
Josef Thaler
Heinz Gisslinger
Alois Lang
Miklós Egyed
Irene Womastek
7 September 2010